Literature DB >> 22334535

Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort.

Bénédicte Leynaert1, Jordi Sunyer, Raquel Garcia-Esteban, Cecilie Svanes, Deborah Jarvis, Isa Cerveri, Julia Dratva, Thorarinn Gislason, Joachim Heinrich, Christer Janson, Nino Kuenzli, Roberto de Marco, Ernst Omenaas, Chantal Raherison, Francisco Gómez Real, Matthias Wjst, Elisabeth Zemp, Mahmoud Zureik, Peter G J Burney, Josep M Anto, Françoise Neukirch.   

Abstract

BACKGROUND: Although women with severe non-allergic asthma may represent a substantial proportion of adults with asthma in clinical practice, gender differences in the incidence of allergic and non-allergic asthma have been little investigated in the general population.
METHODS: Gender differences in asthma prevalence, reported diagnosis and incidence were investigated in 9091 men and women randomly selected from the general population and followed up after 8-10 years as part of the European Community Respiratory Health Survey. The protocol included assessment of bronchial responsiveness, IgE specific to four common allergens and skin tests to nine allergens.
RESULTS: Asthma was 20% more frequent in women than in men over the age of 35 years. Possible under-diagnosis of asthma appeared to be particularly frequent among non-atopic individuals, but was as frequent in women as in men. The follow-up of subjects without asthma at baseline showed a higher incidence of asthma in women than in men (HR 1.94; 95% CI 1.40 to 2.68), which was not explained by differences in smoking, obesity or lung function. More than 60% of women and 30% of men with new-onset asthma were non-atopic. The incidence of non-allergic asthma was higher in women than in men throughout all the reproductive years (HR 3.51; 95% CI 2.21 to 5.58), whereas no gender difference was observed for the incidence of allergic asthma.
CONCLUSIONS: This study shows that female sex is an independent risk factor for non-allergic asthma, and stresses the need for more careful assessment of possible non-allergic asthma in clinical practice, in men and women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22334535     DOI: 10.1136/thoraxjnl-2011-201249

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  81 in total

Review 1.  Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models.

Authors:  Bosung Shim; Gustavo Pacheco-Rodriguez; Jiro Kato; Thomas N Darling; Martha Vaughan; Joel Moss
Journal:  Eur Respir Rev       Date:  2013-09-01

2.  Impact of Age and Sex on Response to Asthma Therapy.

Authors:  Ryan M Dunn; Erik Lehman; Vernon M Chinchilli; Richard J Martin; Homer A Boushey; Elliot Israel; Monica Kraft; Stephen C Lazarus; Robert F Lemanske; Njira L Lugogo; Stephen P Peters; Christine A Sorkness; Stanley Szefler; Michael E Wechsler
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

3.  Maternal microchimerism protects against the development of asthma.

Authors:  Emma E Thompson; Rachel A Myers; Gaixin Du; Tessa M Aydelotte; Christopher J Tisler; Debra A Stern; Michael D Evans; Penelope E Graves; Daniel J Jackson; Fernando D Martinez; James E Gern; Anne L Wright; Robert F Lemanske; Carole Ober
Journal:  J Allergy Clin Immunol       Date:  2013-02-21       Impact factor: 10.793

4.  Perinatal bisphenol A exposure beginning before gestation enhances allergen sensitization, but not pulmonary inflammation, in adult mice.

Authors:  E O'Brien; I L Bergin; D C Dolinoy; Z Zaslona; R J A Little; Y Tao; M Peters-Golden; P Mancuso
Journal:  J Dev Orig Health Dis       Date:  2014-04       Impact factor: 2.401

5.  Impact of pharmacist-led educational interventions on asthma control and adherence: single-blind, randomised clinical trial.

Authors:  Kosisochi C Amorha; Mathew J Okonta; Chinwe V Ukwe
Journal:  Int J Clin Pharm       Date:  2020-11-02

Review 6.  Asthma is Different in Women.

Authors:  Joe G Zein; Serpil C Erzurum
Journal:  Curr Allergy Asthma Rep       Date:  2015-06       Impact factor: 4.806

7.  Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab.

Authors:  Erminia Ridolo; Francesco Pucciarini; Maria Cristina Nizi; Eleni Makri; Paola Kihlgren; Lorenzo Panella; Cristoforo Incorvaia
Journal:  Hum Vaccin Immunother       Date:  2020-05-13       Impact factor: 3.452

8.  Associations between prenatal exposure to DDT and DDE and allergy symptoms and diagnoses in the Venda Health Examination of Mothers, Babies and their Environment (VHEMBE), South Africa.

Authors:  Fahmida Huq; Muvhulawa Obida; Riana Bornman; Thomas Di Lenardo; Jonathan Chevrier
Journal:  Environ Res       Date:  2020-03-15       Impact factor: 6.498

Review 9.  Estrogen effects in allergy and asthma.

Authors:  Rana S Bonds; Terumi Midoro-Horiuti
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-02

10.  Characterization of immune cell subtypes in three commonly used mouse strains reveals gender and strain-specific variations.

Authors:  Jonathan A Hensel; Vinayak Khattar; Reading Ashton; Selvarangan Ponnazhagan
Journal:  Lab Invest       Date:  2018-10-23       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.